The View from the C-Suite: Immunovaccine Inc. (IMV)
Listing on a public market is one of the most exciting days in a company's growth story. To help mark the occasion, Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) invite listed companies to provide information about their business, their ‘go public' experience and the objectives they aim to achieve, or have achieved, by listing on Canada's leading public markets, TSX and TSXV.
The View from the C-Suite is a video interview series that highlights the unique perspectives of senior executives at listed companies and provide a glimpse into how they think in the current business environment.
Click on the image below to view a video with Marc Mansour, CEO of Immunovaccine Inc. (TSX:IMV), a Halifax-based company that graduated from TSXV to TSX in 2014: